全文获取类型
收费全文 | 302358篇 |
免费 | 26623篇 |
国内免费 | 12574篇 |
专业分类
耳鼻咽喉 | 1791篇 |
儿科学 | 4627篇 |
妇产科学 | 2390篇 |
基础医学 | 43890篇 |
口腔科学 | 5361篇 |
临床医学 | 36961篇 |
内科学 | 43765篇 |
皮肤病学 | 2796篇 |
神经病学 | 38222篇 |
特种医学 | 31759篇 |
外国民族医学 | 52篇 |
外科学 | 20685篇 |
综合类 | 45541篇 |
现状与发展 | 35篇 |
一般理论 | 3篇 |
预防医学 | 8350篇 |
眼科学 | 4817篇 |
药学 | 25074篇 |
153篇 | |
中国医学 | 8660篇 |
肿瘤学 | 16623篇 |
出版年
2024年 | 706篇 |
2023年 | 4075篇 |
2022年 | 7778篇 |
2021年 | 10718篇 |
2020年 | 10249篇 |
2019年 | 9114篇 |
2018年 | 9118篇 |
2017年 | 10175篇 |
2016年 | 11138篇 |
2015年 | 11709篇 |
2014年 | 19798篇 |
2013年 | 21387篇 |
2012年 | 18076篇 |
2011年 | 20139篇 |
2010年 | 16733篇 |
2009年 | 16203篇 |
2008年 | 16635篇 |
2007年 | 16427篇 |
2006年 | 15270篇 |
2005年 | 13094篇 |
2004年 | 10875篇 |
2003年 | 9274篇 |
2002年 | 7422篇 |
2001年 | 6623篇 |
2000年 | 5516篇 |
1999年 | 4627篇 |
1998年 | 4189篇 |
1997年 | 4059篇 |
1996年 | 3443篇 |
1995年 | 3194篇 |
1994年 | 2908篇 |
1993年 | 2400篇 |
1992年 | 2041篇 |
1991年 | 1818篇 |
1990年 | 1533篇 |
1989年 | 1382篇 |
1988年 | 1257篇 |
1987年 | 1117篇 |
1986年 | 1036篇 |
1985年 | 1426篇 |
1984年 | 1285篇 |
1983年 | 905篇 |
1982年 | 1079篇 |
1981年 | 852篇 |
1980年 | 743篇 |
1979年 | 542篇 |
1978年 | 397篇 |
1977年 | 305篇 |
1976年 | 283篇 |
1975年 | 113篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
目的 对比研究朝鲜淫羊藿酸性多糖酯化还原前后的理化特性,并探讨其改善油酸诱导的肝癌HepG2细胞脂质堆积活性的差异。方法 采用高效凝胶渗透色谱法测定朝鲜淫羊藿酸性多糖(EFPA)的均一性和分子量,高效液相色谱法测定EFPA和酯化还原后朝鲜淫羊藿酸性多糖(EFPA-R)的单糖组成;采用油酸(OA)处理HepG2细胞诱导建立脂质蓄积模型,不同浓度EFPA与EFPA-R(10、30、100、300 μg·mL-1)分别和OA共同作用于细胞24 h,采用CCK-8试剂盒测定细胞存活率,油红O染色观察细胞内脂滴蓄积情况,并采用试剂盒测定细胞内总胆固醇(TC)、甘油三酯(TG)含量。结果 EFPA为成分均一的多糖组分,分子量为125.8 kDa,由甘露糖、葡萄糖、半乳糖、葡萄糖醛酸和阿拉伯糖组成,摩尔比为1.7∶7.4∶1.4∶1.8∶1.0,葡萄糖占比最大,EFPA-R由甘露糖、葡萄糖、半乳糖和阿拉伯糖组成,摩尔比为0.8∶10.6∶2.1∶1.0;在10-300 μg·mL-1范围内,EFPA和EFPA-R对HepG2细胞的抑制作用较弱,作为给药浓度;与空白组相比,模型组细胞中TC、TG含量显著升高(P < 0.01),细胞内红色脂滴显著增多,与模型组相比,EFPA可显著降低细胞中TC、TG含量(P < 0.01),明显减少细胞内红色脂滴(P < 0.05或P < 0.01),EFPA-R干预后细胞则无明显变化。结论 EFPA可明显改善HepG2细胞脂质堆积情况,且呈现剂量依赖性,而半乳糖醛酸(GalA)的存在可能是其抑制HepG2细胞脂质蓄积的关键因素。 相似文献
2.
3.
Georg Prokop Benedikt Wiestler Daniel Hieber Fynn Withake Karoline Mayer Jens Gempt Claire Delbridge Friederike Schmidt-Graf Nicole Pfarr Bruno Märkl Jürgen Schlegel Friederike Liesche-Starnecker 《International journal of cancer. Journal international du cancer》2023,153(9):1658-1670
Intratumor heterogeneity is a main cause of the dismal prognosis of glioblastoma (GBM). Yet, there remains a lack of a uniform assessment of the degree of heterogeneity. With a multiscale approach, we addressed the hypothesis that intratumor heterogeneity exists on different levels comprising traditional regional analyses, but also innovative methods including computer-assisted analysis of tumor morphology combined with epigenomic data. With this aim, 157 biopsies of 37 patients with therapy-naive IDH-wildtype GBM were analyzed regarding the intratumor variance of protein expression of glial marker GFAP, microglia marker Iba1 and proliferation marker Mib1. Hematoxylin and eosin stained slides were evaluated for tumor vascularization. For the estimation of pixel intensity and nuclear profiling, automated analysis was used. Additionally, DNA methylation profiling was conducted separately for the single biopsies. Scoring systems were established to integrate several parameters into one score for the four examined modalities of heterogeneity (regional, cellular, pixel-level and epigenomic). As a result, we could show that heterogeneity was detected in all four modalities. Furthermore, for the regional, cellular and epigenomic level, we confirmed the results of earlier studies stating that a higher degree of heterogeneity is associated with poorer overall survival. To integrate all modalities into one score, we designed a predictor of longer survival, which showed a highly significant separation regarding the OS. In conclusion, multiscale intratumor heterogeneity exists in glioblastoma and its degree has an impact on overall survival. In future studies, the implementation of a broadly feasible heterogeneity index should be considered. 相似文献
4.
《Cancer cell》2022,40(2):153-167.e11
- Download : Download high-res image (229KB)
- Download : Download full-size image
5.
6.
7.
8.
《Clinical neurophysiology》2021,132(10):2357-2364
ObjectivesTo investigate the subcortical somatosensory evoked potentials (SEPs) to electrical stimulation of either muscle or cutaneous afferents.MethodsSEPs were recorded in 6 patients suffering from Parkinson’s disease (PD) who underwent electrode implantation in the pedunculopontine (PPTg) nucleus area. We compared SEPs recorded from the scalp and from the intracranial electrode contacts to electrical stimuli applied to: 1) median nerve at the wrist, 2) abductor pollicis brevis motor point, and 3) distal phalanx of the thumb. Also the high-frequency oscillations (HFOs) were analysed.ResultsAfter median nerve and pure cutaneous (distant phalanx of the thumb) stimulation, a P1-N1 complex was recorded by the intracranial lead, while the scalp electrodes recorded the short-latency far-field responses (P14 and N18). On the contrary, motor point stimulation did not evoke any low-frequency component in the PPTg traces, nor the N18 potential on the scalp. HFOs were recorded to stimulation of all modalities by the PPTg electrode contacts.ConclusionsStimulus processing within the cuneate nucleus depends on modality, since only the cutaneous input activates the complex intranuclear network possibly generating the scalp N18 potential.SignificanceOur results shed light on the subcortical processing of the somatosensory input of different modalities. 相似文献
9.
10.